{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:22:27Z","timestamp":1761567747935,"version":"build-2065373602"},"reference-count":14,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,5,8]]},"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1183\/23120541.00581-2025","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:05:28Z","timestamp":1761563128000},"page":"00581-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Unmasking the true value of cystic fibrosis transmembrane conductance regulator modulators"],"prefix":"10.1183","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-1127","authenticated-orcid":false,"given":"Aqeem","family":"Azam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2025102704051404000_11.5.00581-2025.1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00111-2025"},{"key":"2025102704051404000_11.5.00581-2025.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02288-2020"},{"key":"2025102704051404000_11.5.00581-2025.3","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205718"},{"key":"2025102704051404000_11.5.00581-2025.4","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(88)90063-7"},{"key":"2025102704051404000_11.5.00581-2025.5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/M17-0564","article-title":"The cystic fibrosis survival gap: why do Canadians fare better than Americans?","volume":"166","author":"Flume","year":"2017","journal-title":"Ann Intern Med"},{"key":"2025102704051404000_11.5.00581-2025.6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.healun.2020.12.001","article-title":"Bridging the survival gap in cystic fibrosis: An investigation of lung transplant outcomes in Canada and the United States","volume":"40","author":"Stephenson","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2025102704051404000_11.5.00581-2025.7","doi-asserted-by":"crossref","first-page":"100428","DOI":"10.1016\/j.lanepe.2022.100428","article-title":"Impact of COVID-19 pandemic on asthma exacerbations: Retrospective cohort study of over 500,000 patients in a national English primary care database","volume":"19","author":"Shah","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2025102704051404000_11.5.00581-2025.8","doi-asserted-by":"crossref","first-page":"100157","DOI":"10.1016\/j.jacig.2023.100157","article-title":"Effect of the COVID-19 pandemic on asthma exacerbations in New Zealand: an interrupted time series analysis","volume":"2","author":"Chan","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"2025102704051404000_11.5.00581-2025.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255659"},{"key":"2025102704051404000_11.5.00581-2025.10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/antibiotics11081096","article-title":"Impact of the SARS-CoV-2 virus pandemic on patients with bronchiectasis: a multicenter study","volume":"11","author":"Mart\u00ednez-Vergara","year":"2022","journal-title":"Antibiotics"},{"key":"2025102704051404000_11.5.00581-2025.11","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.7861\/fhj.2020-0205","article-title":"The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis","volume":"8","author":"Westcott","year":"2021","journal-title":"Future Healthc J"},{"key":"2025102704051404000_11.5.00581-2025.12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcf.2017.06.002","article-title":"Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor","volume":"17","author":"Flume","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2025102704051404000_11.5.00581-2025.13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jcf.2024.02.014","article-title":"Letter to the editor: A contemporary assessment of CFTR modulator use and eligibility","volume":"23","author":"Rubin","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2025102704051404000_11.5.00581-2025.14","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26954"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00581-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:05:30Z","timestamp":1761563130000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00581-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10,27]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1183\/23120541.00581-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00581-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"type":"electronic","value":"2312-0541"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}